American Healthcare REIT, Inc. (AHR) intrinsic value & 10-year financials
American Healthcare REIT, Inc. (AHR) has a Graham intrinsic value of $13.95 per share. At $53.23 on Oct 17, 2026, the stock trades 282% above that value. Over the last 10 fiscal years revenue grew 109.9% a year to $2.1B, with an average return on invested capital of 16.9%.
- Graham intrinsic value
- $13.95
- Share price (Oct 17, 2026)
- $53.23
- Price vs Graham value
- 282% above
- Market cap
- $8.9B
- Revenue (FY2025)
- $2.1B
- Revenue growth (10-yr CAGR)
- 109.9%
- ROIC (10-yr avg)
- 16.9%
- Free cash flow (FY2025)
- —
AHR 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.1B | $69.8M | $0.42 | — | 19.8% | 14.9% |
| FY2024 | $1.9B | -$37.8M | -$0.29 | — | 19.3% | 20.6% |
| FY2023 | $1.7B | -$71.5M | -$0.54 | — | 18.4% | 23.0% |
| FY2022 | $1.4B | -$81.3M | -$0.62 | — | 21.4% | 20.3% |
| FY2021 | $1.1B | -$47.8M | -$0.12 | — | 19.0% | 20.0% |
| FY2020 | $67.8M | -$18.1M | $0.01 | — | 322.0% | 38.3% |
| FY2019 | $46.2M | -$18.8M | -$0.01 | — | 479.6% | 38.6% |
| FY2018 | $36.9M | -$8.4M | — | — | — | -1.8% |
| FY2017 | $5.6M | $541.0K | — | — | — | 0.2% |
| FY2016 | $0 | -$5.5M | — | — | — | -5.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
American Healthcare REIT, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
American Healthcare REIT, Inc. has earned high returns on invested capital, averaging 16.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
American Healthcare REIT, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, American Healthcare REIT, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $13.95 per share.